VJHemOnc Podcast cover image

Updates on the use of BCMA-targeting bispecific antibodies in R/R multiple myeloma: insights from EHA & ASCO 2024

VJHemOnc Podcast

00:00

Intro

The chapter discusses the results from the Magnetism MM3 trial with elvenetumab and the Maniatism MM3 trial with ranetumab, highlighting the efficacy of ranetumab as a salvage treatment for Relapsed Refractory Multiple Myeloma.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app